Neoantigenics

Recent Finacing

Equity

Recent Raise

Undisclosed

Neoantigenics is a Charlottesville-based biotech developing monoclonal antibody therapeutics targeting oocyte-associated cancer biomarkers and accompanying molecular diagnostic assays for precision, personalized oncology.